ERWINAZE

Drug Jazz Pharmaceuticals Inc.
Total Payments
$94,340
Transactions
75
Doctors
68
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $42.40 2 2
2023 $33.16 1 1
2021 $77.03 1 1
2020 $9,218 13 12
2019 $84,969 58 53

Payments by Nature

Nature of Payment Amount Transactions Share
Grant $75,000 1 79.5%
Consulting Fee $12,113 7 12.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,500 1 3.7%
Food and Beverage $2,656 63 2.8%
Travel and Lodging $1,071 3 1.1%

Top Doctors Receiving Payments for ERWINAZE

Doctor Specialty Location Total Records
Unknown Houston, TX $75,000 1
, MD Pediatric Hematology-Oncology Houston, TX $9,125 3
, MD Pediatric Hematology-Oncology Memphis, TN $4,453 4
, M.D Pediatric Hematology-Oncology Minneapolis, MN $962.50 1
, M.D Pediatric Hematology-Oncology Dallas, TX $792.96 2
, MD Pediatric Hematology-Oncology Miami, FL $550.00 1
, M.D Medical Oncology Baltimore, MD $550.00 1
, M.D, PHD Internal Medicine Houston, TX $500.00 1
, M.D Internal Medicine Los Angeles, CA $125.18 1
, M.D Pediatric Hematology-Oncology Cincinnati, OH $125.18 1
, M.D Pediatric Hematology-Oncology Kansas City, MO $125.18 1
, MD Pediatric Hematology-Oncology Aurora, CO $125.18 1
, M.D Pediatrics Philadelphia, PA $125.18 1
, D.O Pediatric Hematology-Oncology Salt Lake City, UT $125.18 1
, M.D Pediatric Hematology-Oncology Chicago, IL $125.18 1
Stacy Cooper Pediatric Hematology-Oncology Baltimore, MD $125.18 1
, MD Pediatrics Philadelphia, PA $125.18 1
, MD Pediatric Hematology-Oncology Winfield, IL $124.16 1
, MD Nephrology Evanston, IL $124.16 1
, MD Pediatric Hematology-Oncology Nashville, TN $77.03 1
, M.D Pediatric Hematology-Oncology Orange, CA $39.01 1
, MD Pediatrics Orange, CA $39.01 1
, MD Pediatric Hematology-Oncology Madera, CA $33.16 1
, M.D Pediatrics Sioux Falls, SD $23.88 1
, MD Pulmonary Disease Alabaster, AL $23.16 1

About ERWINAZE

ERWINAZE is a drug associated with $94,340 in payments to 68 healthcare providers, recorded across 75 transactions in the CMS Open Payments database. The primary manufacturer is Jazz Pharmaceuticals Inc..

Payment data is available from 2019 to 2024. In 2024, $42.40 was paid across 2 transactions to 2 doctors.

The most common payment nature for ERWINAZE is "Grant" ($75,000, 79.5% of total).